The Trump administration is defending abortion pill access in court. What?

The Trump administration's dismissal of a lawsuit challenging mifepristone has sparked concern over potential future legal challenges to abortion access, as Republican attorneys general now leading the case may signal broader efforts by red states against proposed restrictions on mifepristone. Experts warn this move could foreshadow further intra-state conflicts over abortion rights. Meanwhile, FDA Commissioner Martin Makary hinted at significant regulatory changes under consideration for mifepristone, complicating the administration's stance on protecting reproductive health.